地拉罗司恩瑞格国内有药吗
Is Deferasirox Enrige available in China? At present, Deferasirox (Enrego) has also been launched in China. The domestic specification of Deferasirox (Enrego) is 125mg/tablet*28 tablets/bottle (box), and the price is 2330$, which is not cheap. Although it has been marketed in China, it is not included in the medical insurance catalog, so patients cannot be reimbursed by medical insurance after purchasing the drug. If patients need to take this drug for long-term treatment, the price will be a big burden.
CIPLA Pharmaceuticals, one of the well-known pharmaceutical companies in India, has launched a generic version of Deferasirox (Enrega), with a specification of 500mg*30 tablets/box and a price equivalent to RMB only about $500. The price is much lower than the original drug. For patients who need to take this drug for long-term treatment, the price of the Indian generic version of Deferasirox (Enrige) is more acceptable. Although it is a generic drug, its efficacy is almost the same as that of the original drug, it has the same effect, and the price is more affordable and cost-effective, which is why it has become the choice of many patients. Patients can choose to go abroad to purchase Deferasirox (Enrige) by themselves, but it is not recommended to purchase the drug through purchasing agents. Since the exchange rate floating price is not fixed, if patients want to know the specific price of the drug, or want to purchase Deferasirox (Enrego) overseas, they can consult with domestic reliable overseas medical service institutions (such as Medical Companion Travel).
The daily dosage of Deferasirox (Enrig) dispersible tablets is 20~30 mg/kg, once a day, and the clinical compliance is good. In addition to chelating intracellular iron, Deferasirox (Enrig) is also related to the increase of hepcidin, which can reduce the iron absorption of intestinal cells, so the iron removal effect is better. According to a retrospective study in Italy, 42.7% of patients achieved a hematological response and reduced the need for blood transfusions after receiving chelation therapy with DFO or deferasirox (Enrega).
The above is the introduction about Deferasirox Enrego, I hope it can help everyone. If patients have other questions about the drug, they can consult the medical companion service.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)